RIDGE-1 Gene Therapy Trial for PKP2-ARVC

Thank you for your interest in participating in the Tenaya RIDGETM-1 Gene Therapy Trial for PKP2-ARVC.

A member of the SADS staff will connect you with the site coordinator at the location you chose within the next few business days.

If you have any questions, or have any trouble getting in contact with someone, please don’t hesitate to reach out to us at SADS – you can reply to this email, send an email to [email protected], or call or text 801-948-0654. 

You can read more information about this trial on ClinicalTrials.gov and at arvcstudies.com .